MassRobotics opens Cohort 6 for healthcare robotics, adds Intel

MassRobotics has begun accepting applications for the sixth cohort of its Healthcare Robotics Catalyst Program, now backed by Intel alongside founding partners Festo, Mitsubishi Electric US, and Novanta. The program targets startups developing surgical and procedure-enabling robotics and operating-room automation.

Intel’s Health and Life Sciences team joins the steering committee, bringing expertise in edge AI and on-device compute. The company’s involvement follows a year of rising interest in robotics applications beyond warehouses and logistics. When we covered Amazon’s $100 million robotics plant in Indiana last month, it marked the e-commerce giant’s fourth such facility in the U.S., yet healthcare remains a distinct opportunity—one where regulatory and technical hurdles may demand deeper corporate partnerships.

The Catalyst Program’s focus on mentorship and technical resources reflects a broader shift in how robotics startups access capital and expertise. Some startups in the space have reportedly secured significant funding, though surgical and procedural automation often requires longer development timelines. Intel’s participation suggests investors may see value in startups that can integrate AI at the edge, reducing latency and improving reliability in clinical settings.

Applications are open now, with no disclosed deadline or cohort size. For founders, the program offers more than funding—it’s a test of whether their hardware can meet the demands of hospitals and surgical teams. The addition of Intel could shape the program’s direction, though its impact on commercialization remains to be seen.

Sources: financialcontent.com